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Local Microwave Hyperthermia in Cancer Therapy
Preliminary report
Carlos A. Perez, MD,* Walter Kopecky, PhD,* Robert Baglan, MD,* D. Venkata Rao, MD,* and
Richard Johnson, MD**

This report summarizes our preliminary experience at the
Mallinckrodt Institute of Radiology treating 26 patients with
metastatic tumors with hyperthermia and irradiation. Patients received 400 rad fractions given every 72 hours
(twice weekly) for a total of 2400, 2800, 3200, or 4000 rad
followed by hyperthermia. In addition, 18 lesions were
treated according to a protocol designed by the Radiation
Therapy Oncology Group (RTOG) for superficial measurable tumors to receive three doses of 500 rad followed by
hyperthermia (six lesions) or irradiation alone (three doses
of 600, 700, or 800 rad) every 72 hours.

radiotherapy alone. We observed that 1500 rad and hyperthermia together were not as effective as higher doses of
irradiation alone. Better results were obtained on an intramural protocol that combined higher doses of irradiation
with hyperthermia.
The doses of radiation and heat delivered have been extremely well tolerated by normal tissues. Of the 34 sites
treated, three (8%) developed blisters, three (8%) erythema
only, three (8%) moist desquamation, and 14 (41%) dry
desquamation. No instances of ulceration, necrosis, or
severe fibrosis have been observed in the treated areas,
even in the patients surviving over one year.

Hyperthermia was administered with 2450 MHz or 915
MHz microwave generators and appropriately designed
surface applicators. Temperatures were maintained at
42.5°-43X: for 90 minutes at 72-hour intervals. Irradiation
was delivered with 12 to 16 Mev electrons, as required by
the size of the lesions, and occasionally with Cobalt 60.

We feel that additional clinical trials are warranted to assess
the potential value of hyperthermia alone or combined
with irradiation to treat selected cancer patients. Intensive
efforts will be required to improve existing methods for
delivery and measurement of heat to lesions more than
5 cm deep.

Our first protocol treated six lesions with a combination of
irradiation and hyperthermia and 12 control lesions with

T h e damaging effect of heat on malignant cells was first
reported by Busch (1), who described the disappearance of
a sarcoma following high fever in a patient with erysipelas.
Other encouraging reports followed: Coley (2) used bacterial toxins to induce fever; and Westermark (3) treated
malignant tumors wfth localized hyperthermia. Despite
these and other reports by Rohdenburg in 1918 (4) and
Warren in 1935 (5), hyperthermia has had minimal clinical
application (6-9).

Indicate that the use of heat or heat combined with irradiation or cytotoxic drugs may enhance the killing of tumor
cells (10-12). However, clinical use of localized or whole
body heat has been severely hampered by inadequate
equipment and unreliable thermometry techniques. The
equipment has been unable to deliver effective heat to
deep-seated lesions, and thermometry techniques have not
provided information about the distribution of heat in the
target tissues. Various institutions throughout the world
have begun to gather information on tolerance of normal
tissues to hyperthermia alone or combined wfth radiation.
Several forms of heat (radiofrequency, microwave, or ultrasound) are being used in order to establish optimal hyperthermia parameters that w i l l enhance t u m o r cell kill
without destroying normal tissues.

Interest in heat treatment of malignancies has been revived
in the past ten years, however. Many published reports
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The following is a report of preliminary observations made
on a selected group of patients with recurrent or metastatic
superficial nodules treated over a two-year period
(1978-1979) at the Mallinckrodt Institute of Radiology.
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Intramural protocol

Materials and Methods

The Washington University intramural protocol treated patients who had recurrent lesions from epidermoid carcinoma
ofthe head and neck or adenocarcinoma ofthe breast, most
of which had been previously irradiated with doses ranging
from 4000 to 6000 rad. Other tumors included several
metastatic melanoma nodules (Tables I and II).

During 1978 and 1979, we treated 26 superficial tumors
with hyperthermia and irradiation at the Mallinckrodt Institute of Radiology. Irradiation doses consisted of 400 rad
fractions given every 72 hours (twice weekly) for a total of
2400, 2800, 3200 or 4000 rad, in orderto assess tolerance
of normal tissues and tumor response fthree to five patients
per dose). In addftion, 18 lesions were treated accordingto
a protocol designed by the Radiation Therapy Oncology
Group (RTOG). Superficial measurable tumors and randomized lesions received three doses of 500 rad followed
by hyperthermia (43°C, 90 minutes, every 72 hours), or
irradiation alone fthree doses of 600, 700, or 800 rad every
72 hours). Further, two recurrent nodules of head and neck
epidermoid carcinoma and three extensive recurrences
from carcinoma of the breast in the chest wall were treated
with heat alone.

Four of six recurrent epidermoid carcinomas of the head
and neck showed complete regression, and two others
showed 20% and 40% regression. Of three metastatic
melanoma nodules treated with irradiation and hyperthermia, two showed complete regression and one 80% regression, all lasting from five to eight months.
One of the patients treated with heat alone showed complete regression of a 4x3x1 cm subcutaneous nodule with
superficial ulceration of the left neck. The nodule had
appeared ^V2 years after 5700 rad TD had been delivered
to the neck w i t h Cobalt 60 and after a supraglottic
laryngectomy. The patient has remained free of disease 15
months after therapy. Another patient, with a 7x3x5x.5 cm
recurrent epidermoid carcinoma o f t h e scalp, was treated
with heat alone. Most of the tumor regressed completely,
but a persistent nodule at the margin was treated with 4500
rad TD in 15 fractions; he also received superficial x-rays
(120 KV, .3 mm cu HVL) for three weeks. He died eight
months later wfth cirrhosis of the liver, but wfth no evidence of a recurrent tumor (Fig. 1).

We used microwave generators (2450 and 915 MHz) with
specially designed thermocouples (13), which were inserted at the depth of the tumor and over the skin surface.
The temperature at these two sites was continuously recorded on a dual channel chart recorder. Irradiation was
delivered with 12 to 16 Mev electrons, depending on the
lesion size, and occasionally with Cobalt 60, in which case
a bolus was used to increase the surface dose.

Results
RTOG protocol 77-10

Of the three metastatic melanoma nodules treated with
irradiation and hyperthermia, two showed complete regression that lasted from five to 10 months. One patient had
two lesions (Fig. 2), one of which was treated with irradiation (5000 rad) and hyperthermia, with practically complete regression that lasted eight months. As a control, the
second lesion was treated with irradiation alone, resulting
in 75% regression and regrowth wfthin six months of
therapy (Fig. 3). The patient died w i t h widespread
metastases.

Six lesions were treated with irradiation and hyperthermia;
two metastatic melanomas showed complete regression,
and three tumors showed partial regression (one metastatic
epidermoid carcinoma in the abdominal wall, a melanoma, and a recurrent ductal breast carcinoma ofthe chest
wall). The two melanoma nodules showing complete regression remained under control for 12 and 16 months after
therapy. One metastatic melanoma nodule showed no
significant regression. Some lesions did not show clinical
regression probably because the patients died within weeks
of therapy.

In eight recurrent adenocarcinomas of breast lesions in the
chest wall, two that were treated with doses of 2000 rad
showed minimal tumor regression and regrew within two
months of treatment. In contrast, of six other lesions treated
with eight or 10 fractions of 400 rad each, four exhibited
100% regression, and two showed 80%, with about three
months' duration.

Twelve control lesions, mostly melanoma or recurrent carcinoma of the breast, were treated with doses of irradiation
alone that varied from 1800 to 2400 rad in three fractions.
Nine showed complete regression, while three experienced 50% or more tumor regression. In some patients the
lesions remained under control for 12 to 16 months after
therapy.

Due to previous high doses of irradiation, three patients
with rather extensive recurrent adenocarcinoma of the
breast and the chest wall were treated wfth heat alone; the
result was less than 25% regression.

This study indicates that 1500 rad and hyperthermia were
not as effective as higher doses of irradiation. On this basis,
an intramural protocol was initiated that delivered higher
doses of irradiation.
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TABLE I
Hyperthermia Study
RTOG 77-10

Histology

Initial
Size mm

XRT Dose

Hyperthermia

Maximum Skin
Subcutaneous
Reaction

R Axilla

Epidermoid

14x14

700x3

None

2.

R Breast

Epidermoid

22x28

800x3

3.

L Upper
Thigh
L Upper
Thigh
L Lower
Thigh
R Chest
Wall
R Scapula
L Thigh
L Inguinal
Area
L Inguinal
Area
Abdominal
Wall
L Groin
Ant Abd
Wall
Left Mid
Thigh
Left Mid
Thigh
R Chest
Wall
Left
Thigh
Left
Knee

Melanoma

25x25

Melanoma

Tumor
Site

1.

Lesions

4.
5.
6.
7.
8.
9,
10.
11.
12.
13.
14.
15.
16,
17.
18.

% Maximum
Tumor
Regression

Response
Duration
(Months)

None

50%

None

None

50%

Expired
6 Wks Post
Expired
6 Wks Post

600x3

None

None

100%

12

10x10

600x3

None

None

100%

12

Melanoma

5x5

700x3

None

—

100%

12

Ductal
Ductal
Melanoma

15x15
25x25
10x10

700x3
800x3
700x3

None
None
None

—
—
Moist Desq

100%
100%
100%

3
3
16

Melanoma

20x35

800x3

None

Moist Desq

100%

16

Melanoma

25x40

800x3

None

Moist Desq

100%

^6

Melanoma
Melanoma

15x15
20x16

800x3
800x3

None
None

100%
70%

Epidermoid

26x22

500x3

2450 MHz

None
None
Blister at
Margin

50%

6
6
Expired
6 Wks Post

Melanoma

50x50

500x3

2450 MHz

Blister

100%

12

Melanoma

7x7

500x3

2450 MHz

60%

4

30x30

500x3

2450 MHz

Blister
Moist Desq
and Blister

25%

3

10x10

500x3

2450 MHz

Moist Desq

100%

16

10x10

500x3

915 MHz

0%

—

Ductal

Melanoma

None

Normal tissue reactions

Discussion

Normal tissues have tolerated heat and radiation doses
extremely well. Of 34 sites treated, three (8%) developed
blisters, three (8%) erythema only, three (8%) had moist
desquamation, and 14 (41%) dry desquamation. By contrast, three patients treated with irradiation doses of 2100
and 2400 rad in three fractions d e v e l o p e d moist desquamation (5%).

From preliminary studies it is apparent that heat alone or
optimally combined with irradiation has the capacity to
destroy tumor cells and thus has potential clinical applications for treating cancer.
Several explanations may account for these findings: 1) a
reduced blood supply to the tumor; 2) the heat sensitivity of
hypoxic cells, which is complicated, accordingto Dewey
(11), bythe possible association of low oxygen tension with
nutrient deficiency or reduced p H ; 3) metabolically deprived tumor cells with reduced p H ; 4) the effect of heat on
S phase cells, which are known to be resistant to irradiation

We have seen no ulceration, necrosis, or severe fibrosis in
the treated areas, even in patients surviving more than one
year. Fibrosis due to previous radiotherapy has not been
aggravated by the additional hyperthermia and irradiation
treatment.
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(10,11,14); and 5) the greater degree of mitotic delay caused
by heat that affects the distribution of cells in the cell cycle
(15,16).

heating time or less than .5°C at the critical temperature
would increase the probability of tissue necrosis from zero
to 100%. According to Henriques (18), at temperatures
higher than 43.5°C, an increase of 1°C is equivalent to a
decrease in heating time by a factor of two, and vice versa.
In clinical applications, it is obviously important to measure temperatures accurately and deliver them uniformly.

Temperature and time of heat exposure
In vitro and in vivo experiments demonstrate that greater
cell kill occurs as temperatures rise above 42°C. Moritz and
Henriques (17) calculated that an increase of only 20% in

TABLE II
Phase I-II Hyperthermia Study*
Epidermoid CA, Head and Neck, Recurrent

Lesions

Percent
Regression

Duration
(Months)

Normal
Tissue
Reaction
Dry Desq
Dry Desq

Site of Tumor

Size (cm)

Left Neck
Scalp

4x3
7x3.5

100
100

13
8

Floor of Mouth
Left Neck
Right Neck
Right Neck
Left Neck
Left Neck

.5x3.5
4x3
4x4
2.5x2

20
40
100
100
100

2
1
3
2
5
7

Dry
Dry
Dry
Dry
Dry
Dry

Heat Alone
1.
2.
3.
4.

5.
6.
7.
8.

Heat and XRT
400 Radx6
400 Radx7
400 Radx8
400 Radx6
400 RadxtO
400 Radxio

—
—

too

Desq
Desq
Desq
Desq
Desq
Desq

Adenocarcinoma
Heat Alone
9.
10.
11.

Breast/Chest Wall
Breast/Chest Wall
Breast/Chest Wall

18x15
18x9
15x11

25
25
15

1
6
2

Dry Desq
Dry Desq
Dry Desq

Heat and XRT
12.
400 Radx5
13.
400 Radx5
14.
400 RadxtO
15,
400 Rad x i o
16,
400 RadxIO
17.
400 RadxIO
18.
400 Radx8
19.
400 RadxS
(All Patients Had Previous Irradiation

Breast/Right Neck
Breast/Axilla
Breast/Neck Nodes
Breast/Neck Nodes
Breast/Neck Nodes
Breast/Chest Wall
Lung/Right Neck
Lung/Chest Wall
To Site Now Treated)

5x3
3x2
5.5x3
5x2
4x2.5
3x3
1x.5
1x.5

10
16

80
80

2
2
1
1
1
5
3
3

Dry Desq
Dry Desq
Dry Desq
Dry Desq
Dry Desq
Erythema
Erythema
Erythema

too
too
too
too

Metastatic Melanoma
20,
21,
22,
23.
24,

Heat and XRT
400 RadxS
400 RadxS
400 RadxS -i500 RadxS
XRT Alone
400 Radx5 -i500 Radx6

Right PostAuricular
Groin
Right Leg
Right Leg

2x1.5

too

7

Dry Desq

8x3
5x4.5
5x4.5

too

5

80

8

Erythema
Dry Desq
Dry Desq

Right Leg

5x5

60
(Regrowth)

8

Dry Desq

100

7

too
too

4

Dry Desq
Dry Desq
Dry Desq

Soft Tissue Sarcoma
25.
26.

Heat and XRT
400 RadxtO
400 R a d x i l
400 Radxtl

Left Forehead
Right Temporal
Right Temporal

3.5x3.5
4.5x4
2.5x2.5

'915 MHz, 42.5''-43°C, for 90 minutes
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Fig. 1
Recurrent epidermoid carcinoma of the scalp treated with heat alone. Most ofthe tumor underwent complete legressbn, but a persistent nodule at the
margin was treated with 4500 rad TD in 15 fractions, three weeks with superticial x-rays (120 KV, .3 mm cu HVL). Right: Complete regressbn of the
tumor seven months after treatment.

Fractionation and thermal tolerance

before or after irradiation has been administered. The
increased cell kill follows the pattern of direct heat injury,
not that of irradiation; thus the effect on the radioresistant S
phase cell is greater than on the more radiosensitive cells in
other portions o f t h e cell cycle (late Gl or G2 interface).

Henle and Leeper (19) have demonstrated in vitro that
fractionated hyperthermia may result in thermal tolerance
in most cultured mammalian cells and in all normal tissues
evaluated. The time and level of maximal thermal tolerance depend upon the degree of damage induced by the
first heat treatment (20-22). Because thermal tolerant cells
may be more resistant to irradiation (19,23,24), this is an
even more important problem when both modalities are
combined. Field and Bleehen (12) have also noted that low
heating times at moderate temperatures may induce thermal resistance.

Dewey, et al (10) and Sapareto, et al (26) have also shown
that cells at low pH are less efficient in repairing sublethal
heat damage, which can interact with sublethal radiation
damage. Dewey (11) has hypothesized that if heat is delivered three hours before irradiation, cells with a low pH will
have minimal ability to repair heat damage and therefore
may be greatly sensitized to the effects of subsequent
irradiation. In vivo data reported by Overgaard (25) and
Stewart and Denekamp (14) in animals suggest that when
irradiation is delivered before heat, skin behaves like cells
with normal pH and tumor cells like those with low pH.
However, when heating precedes irradiation, the effect on
the skin parallels the effects demonstrated by in vitro
experiments. For tumors, the data are not reproducible.

Sequential administration of heat and irradiation
Ongoing experiments to separate thermal and nonthermal
effects produced by such heating methods as ultrasound
and radiofrequency hyperthermia are exploring the effect
of heat, or heat combined wfth irradiation or cytotoxic
agents, on tumor regression and normal tissue injury.
Hyperthermia appears particularly effective against centrally located hypoxic cells, while irradiation eliminates
tumor cells in the periphery. After Overgaard and Overgaard (25) treated a mouse mammary carcinoma with 27
MHz microwave, they observed that the central portion of
the tumor was more severely damaged than the periphery.

Recent hyperthermia clinical trials, combining heat with
irradiation by microwave, radiofrequency, and ultrasound,
have reported promising results that warrant further clinical
trials.

Dewey, et al (10) and Sapareto, et al (26) have shown in
vitro that the combined use of heat and irradiation results in
greater cell kill than heat delivered more than 30 minutes

Hornback, et al (7) combined microwave (433 MHz) and
ionizing radiation (from 110 rad in two weeks to 6000 rad
in six weeks) to treat 70 patients with advanced malignant

Microwave
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RECURRENT MELANOMA
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Fig. 3
Tumor regression of several metastatic melanoma nodules.

Recently, Bicher, et al (27) treated 23 patients encompassing 37 treatment fields wfth microwave (2450, 915, and
300 MHz), in which the skin was cooled by air jeL Tissue
temperature was kept at 45°C when hyperthermia alone
was used, and at 42°C when ft was combined with radiation. Patients received four treatments of hyperthermia
alone (twice a week at 72-hour intervals), then rested for
one week. Thereafter, each succeeding hyperthermia treatment was preceded by a 400 rad fraction or irradiation
delivered in four combined treatments (atotal of 1600 rad).
Of the tumors treated in the areas of skin, brain, breast, and
spinal cord, 62% disappeared completely. Melanomas and
lymphomas were the most sensitive to treatment, while
sarcomas were the most resistant; adeno and squamous
cell carcinoma were intermediate in response. No toxicity
induced by this combination has been detected, even in
areas previously irradiated to high doses.
Arcangeli, et al (28) reported on a group of 15 patients with
N2 and N3 multiple cervical lymph nodes for head and
neck cancer who received combined microwave and irradiation. They received combined local microwave hyperthermia (2450 or 915 MHz) and multiple daily fractionation
radiotherapy (total doses of 4000-7000 rad). Seventeen of
20 l y m p h nodes (85%) treated w i t h this c o m b i n a t i o n
showed complete regression, compared wfth six of 13
(46%) treated with multiple fractionation irradiation alone,
and 14 of 46 (30%) with lymph nodes treated with conservative fractionation radiotherapy (historical controls). The
authors did not observe any enhanced normal tissue
reactions.

Fig. 2
Top: Pretreatment photograph of two large ulcerated metastatic nodules(4 cm in diameter) in the leg. The lesbn on the left was treated with a
combinatbn of irradiatbn (500 rad in 11 fractbns) and hyperthermia;
the lesbn on the right was treated with the same dose of irradiation but
without heat. Bottom: Photograph six months after therapy showing over
90% regression of the tumors. The lower lesion, treated with irradiation
alone, recurred shortly thereafter.

tumors of various histological types. Twenty-one completed the planned course of treatment and were followed
for a minimum of nine months. He reported that 90%
experienced complete relief of symptoms and 80% experienced complete tumor regression. Nine of those who responded completely remained free of tumor nine to 14
months after therapy. The combined treatment was well
tolerated without significant skin or subcutaneous tissue
injury.

Radiofrequency
Kim and Hahn (29) reported partial and transitory tumor
regressions in 10 of 19 patients treated with 27.2 MHz
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radiofrequency inductive heating (30 minutes at 42°C). In
contrast, the same authors observed partial or complete
tumor regression in 42 of 54 patients who received a
combination of heat immediately before irradiation (1000
to 2000 rad). Enhanced skin reactions following the combined therapy were reported in patients who had been
treated to areas involving skin grafts or extensive fibrosis
from previous surgical procedures.

cal use, a number of technological problems must be
solved. The currently existing hyperthermia modalities,
microwave, radiofrequency, and ultrasound, all have several disadvantages that are major obstacles to clinical
application (32). These include the lack of uniform heat
distribution to deep-seated tumors (3 cm penetration of 915
MHz and 4 cm for 433 MHz microwave), located in the
thorax, abdomen, or pelvis. Lower frequencies (27 MHz)
may provide better depth temperature, but heat deposition
is diffuse and cannot be localized to small volumes.

LeVeen, et al (30) described tumor regression in 21 patients
with different malignant neoplasias treated with radiofrequency (13.56 MHz). However, it is difficult to ascertain
from their publication exactly how many patients had
complete or partial tumor regression and how many survived for extended periods of time after therapy.

Thermometry techniques also need improvement. Invasive
thermometry, which must be used wfth each application,
causes considerable patient discomfort. In addition, hyperthermia with ultrasound cannot be carried out wfth deepseated tumors unless they are near a natural hollow viscera,
such as the esophagus, bladder, rectum, etc. Unfortunately,
only a few points of temperature can be measured, since in
steady state phantoms thermal distribution is not homogeneous. In addition, the temperature drops in deep tissues,
dueto absorption and dissipation (32). Also, the intricacies
of the relationship between microcirculation, blood flow,
and temperature distribution have just begun to be explored (33).

Ultrasound
Marmor, et al (31) reported their results in 26 evaluable
courses of ultrasound hyperthermia for 21 patients with
superficial metastatic or recurrent malignant tumors. They
received a minimum of 43°C for 30 minutes three times
weekly, and tumor response was analyzed after six treatments. Three (12%) showed complete response, and 11
(42%) showed a partial response. Squamous cell carcinoma lesions of the head and neck showed one complete
regression. There were four instances of extensive central
tumor necrosis, and five patients developed small superficial cutaneous burns that healed in seven to 10 days. Ten of
the 26 courses produced significant pain during the ultrasound irradiation, which usually subsided after the treatment was completed. No significant correlation was found
between the temperature in the center of the tumor and the
injury to the normal tissue, except that central necrosis
appeared in four cases with temperatures above 44Xi.
Previous irradiation of the treated area did not lower the
tolerance of normal tissues to ultrasound.

For future clinical use, stringent quality control programs,
like those for irradiation, must be designed to determine
accuracy of heat absorption in tissues and to monitor
temperatures at various sites during the administration of
hyperthermia. Dosimetric observations have documented
the lack of u n i f o r m i t y in heat d i s t r i b u t i o n w i t h some
modalities and applicators as well as the non-uniform
distribution of heat in most tumors. The Radiation Therapy
Oncology Group is developing a collaborative hyperthermia physics reference center to provide the standard for
dosimetry in clinical trials conducted by this group. In
addition, major efforts and funds should be devoted to the
design and development of invasive and noninvasive clinical thermometry technology, ft is extremely difficult to do
in situ measurements at multiple sites in deep-seated tumors. Therefore, noninvasive thermometry techniques
must be developed in appropriate models, using a few
reference points, such as in the surface and the center of
the tumor, when clinically feasible. As the technology
evolves, clinical trials must be continued to determine the
optimal schemas for administering heat and irradiation of
drugs that will produce the maximum therapeutic gain.

Marmor and Hahn (9) described 16 patients with recurrent
tumors who received 18 courses of irradiation with ultrasound after doses of irradiation ranging from 4400 to
11,000 rad. Eleven ofthe 18 courses of ultrasound resulted
in two complete tumor regressions. In addition, five previously irradiated patients were given six courses of heat
plus low dose irradiation (1200 to 2400 rad), three of whom
showed a complete tumor response and two a partial
tumor regression. This finding suggests that the combination of heat and irradiation was more effective than ultrasound alone.
In view of these preliminary observations, additional clinical trials are warranted to assess the potential value of
hyperthermia alone or combined with irradiation to treat
selected cancer patients.
Unfortunately, before hyperthermia reaches optimal clini-
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